A Study of TY-1091 in Patients With Advanced Solid Tumors

Clinical trial NCT05675605 · UNKNOWN

Trial details

NCT number: NCT05675605
Sponsor: TYK Medicines, Inc
Status: UNKNOWN
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

RET-altered Non Small Cell Lung Cancer Medullary Thyroid Cancer RET-altered Papillary Thyroid Cancer Neoplasms

Start date: 2023-04-24
Primary completion: 2025-06-01
Enrollment: 248

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.